# Hemab Therapeutics Holdings, Inc. (COAG)

> Cited company facts from SEC filings, by Steadybase. Web page: https://steadybase.io/company/hemab-therapeutics-holdings-inc/ JSON: https://steadybase.io/company/hemab-therapeutics-holdings-inc.json Checked Nov 21, 2026. Latest filing read: Nov 10, 2026.

## Company

- Legal name: Hemab Therapeutics Holdings, Inc.
- Ticker: COAG (Nasdaq)
- SEC CIK: 0002114044
- Industry: Biological Products, (No Diagnostic Substances) (SIC 2836)
- Headquarters: Cambridge, MA
- Fiscal year ends: December 31
- SEC filer category: <br>Emerging growth company
- Website: hemab.com
- Investor relations: https://ir.hemab.com/
- LinkedIn: https://www.linkedin.com/company/hemabaps
- Next earnings date: Jan 31, 2027

## Key facts

- Shares outstanding: 46,730,608 as of Oct 30, 2026 (10-Q filed Nov 10, 2026). Source: https://www.sec.gov/Archives/edgar/data/2114044/000119312526455376/0001193125-26-455376-index.html

## Business

Hemab is pioneering the first preventative treatments and functional cures for patients with rare bleeding and thrombotic disorders.

Source: Company website description, https://www.hemab.com/

## Officers and directors

- Ananthram Sreenivasa Murthy, Chief Operating Officer. Source: Form 3 filed Apr 30, 2026, https://www.sec.gov/Archives/edgar/data/2114044/000119312526198207/0001193125-26-198207-index.htm
- Catherine Madigan, Chief Medical Officer. Source: Form 4 filed May 4, 2026, https://www.sec.gov/Archives/edgar/data/2114044/000119312526204041/0001193125-26-204041-index.htm

## Recent 8-K events

- Nov 10, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/2114044/000119312526454414/d22670d8k.htm
- Sep 24, 2026: Item 5.02, Departure or appointment of directors or officers; compensation. Source: https://www.sec.gov/Archives/edgar/data/2114044/000119312526401010/d35700d8k.htm
- Aug 11, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/2114044/000119312526343421/d180684d8k.htm
- May 21, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/2114044/000119312526233375/d102408d8k.htm
- May 11, 2026: Item 5.02, Departure or appointment of directors or officers; compensation. Source: https://www.sec.gov/Archives/edgar/data/2114044/000119312526216699/d141757d8k.htm
- May 4, 2026: Item 5.03, Amendments to articles or bylaws; change in fiscal year; Item 8.01, Other events; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/2114044/000119312526203988/d149100d8k.htm

## Insider trades (Form 4)

- May 6, 2026: Peter Kolchinsky (Director) bought 2,840,429 shares, about $52.2M. Source: https://www.sec.gov/Archives/edgar/data/2114044/000123191926000457/0001231919-26-000457-index.htm
- May 6, 2026: Rajeev M. Shah (Director) bought 2,840,429 shares, about $52.2M. Source: https://www.sec.gov/Archives/edgar/data/2114044/000123191926000457/0001231919-26-000457-index.htm
- May 6, 2026: Capital Nexus Fund L.P. RA II (Director) bought 2,840,429 shares, about $52.2M. Source: https://www.sec.gov/Archives/edgar/data/2114044/000123191926000457/0001231919-26-000457-index.htm
- May 6, 2026: Capital Nexus Fund L.P. RA IV (Director) bought 2,840,429 shares, about $52.2M. Source: https://www.sec.gov/Archives/edgar/data/2114044/000123191926000457/0001231919-26-000457-index.htm
- May 6, 2026: Capital Healthcare Fund LP RA (Director) bought 2,840,429 shares, about $52.2M. Source: https://www.sec.gov/Archives/edgar/data/2114044/000123191926000457/0001231919-26-000457-index.htm
- May 6, 2026: Capital Management L.P. Ra (Director) bought 2,840,429 shares, about $52.2M. Source: https://www.sec.gov/Archives/edgar/data/2114044/000123191926000457/0001231919-26-000457-index.htm

## Latest filings

- 8-K filed Sep 24, 2026: https://www.sec.gov/Archives/edgar/data/2114044/000119312526401010/d35700d8k.htm
- 10-Q filed Aug 11, 2026: https://www.sec.gov/Archives/edgar/data/2114044/000119312526344533/coag-20260630.htm

## About this data

SEC EDGAR filings, read by Steadybase. Every value links to the filing it came from.
Steadybase covers US-headquartered public companies that file with the SEC. API and MCP access: https://steadybase.io/docs/

